Quick Answer
Evolus, Inc. reported R&D Expense of $2.06 million for fiscal year 2021.
Evolus, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $2.06M | +19.9% |
| 2020 | $1.72M | -56.7% |
| 2019 | $3.97M | -38.8% |
| 2018 | $6.49M | -3.0% |
| 2017 | $6.69M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $468.0K | -44.4% | +55.5% |
| September 30, 2021 | $301.0K | -14.0% | -39.7% |
| June 30, 2021 | $499.0K | +244.1% | -40.7% |
| March 31, 2021 | $841.0K | +65.9% | +140.3% |
| September 30, 2020 | $350.0K | -49.5% | +141.4% |
| June 30, 2020 | $145.0K | -71.5% | -71.4% |
| March 31, 2020 | $507.0K | -78.5% | -26.8% |
| September 30, 2019 | $693.0K | -64.9% | +36.1% |
- Evolus, Inc. showed an increase of +19.9% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2021 period, Evolus, Inc.’s r&d expense has declined by 69.1% (from $6.69 million to $2.06 million).
- The most recent figure is from Evolus, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 3, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: